Using a preclinical model, an RNA ligand‐tethered lipid nanoparticle (AA‐T3A‐C12) has shown about ∼65% silencing of HSP47, leading to a significant reduction in liver fibrosis.131. The gene discussed is SERPINH1; the disease is Hepatic fibrosis.